149 related articles for article (PubMed ID: 11043017)
1. The efficacy and safety of cefaclor in respiratory infections amongst Pakistani children.
Najam Y; Walla FL; Iqbal A; Khan MK; Aqil S; Sharif MW; Masood T; Gaba I; Malik BA; Hassan M; Malik S; Hassan S; Bukhari KA; Khawar N; Tarar MA
J Pak Med Assoc; 2000 Sep; 50(9):289-93. PubMed ID: 11043017
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010].
Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX
Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
[TBL] [Abstract][Full Text] [Related]
4. Determination of antimicrobial activity of Cefaclor on common respiratory tract pathogens in Pakistan.
Ahmed A; Hafiz S; Rafiq M; Tariq N; Abdulla EM; Hussain S; Azim R; Siddiqui SJ; Awan A; Khan KZ; Fareed A
J Pak Med Assoc; 2002 Jan; 52(1):7-11. PubMed ID: 11963587
[TBL] [Abstract][Full Text] [Related]
5. Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
Blumer JL; Mclinn SE; Deabate CA; Kafetzis DA; Perrotta RJ; Salgado O
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S115-20. PubMed ID: 7567311
[TBL] [Abstract][Full Text] [Related]
6. Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection.
Infection; 1991; 19(4):208-15. PubMed ID: 1917031
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
Piippo T; Stefansson S; Pitkäjärvi T; Lundberg C
Scand J Infect Dis; 1991; 23(4):459-65. PubMed ID: 1957129
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of cefaclor in Pakistani children with pharyngotonsillitis.
Siddiqui SJ; Awan A; Ekangakic A; Stocks JM; Sheikh GA; Ahmad TM; Mian FA; Kanjee S; Sheikh S; Rashid A; Yousfani AH; Talat A; Ahmad M
J Pak Med Assoc; 2002 Oct; 52(10):451-6. PubMed ID: 12553673
[TBL] [Abstract][Full Text] [Related]
10. Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
Iancu TC; Sinoff G
Isr J Med Sci; 1983 Nov; 19(11):998-1000. PubMed ID: 6662693
[TBL] [Abstract][Full Text] [Related]
11. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
Leveque B; Lambert-Zechovsky N; Cathlin C
Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
[No Abstract] [Full Text] [Related]
12. Etiology of acute otitis media in childhood and evaluation of two different protocols of antibiotic therapy: 10 days cefaclor vs. 3 days azitromycin.
Oğuz F; Unüvar E; Süoğlu Y; Erdamar B; Dündar G; Katircioğlu S; Sidal M
Int J Pediatr Otorhinolaryngol; 2003 Jan; 67(1):43-51. PubMed ID: 12560149
[TBL] [Abstract][Full Text] [Related]
13. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of bacterial pathogens in the oropharynx of healthy school children in Turkey.
Gazi H; Kurutepe S; Sürücüoğlu S; Teker A; Ozbakkaloglŭ B
Indian J Med Res; 2004 Nov; 120(5):489-94. PubMed ID: 15591635
[TBL] [Abstract][Full Text] [Related]
15. Bacteriological aspects of infections of the upper respiratory tract.
Kallings LO
Scand J Infect Dis Suppl; 1983; 39():9-13. PubMed ID: 6580737
[TBL] [Abstract][Full Text] [Related]
16. [Distribution and drug resistance of the isolated bacteria from children with acute respiratory infection].
Guo J; Cui ZZ; Huang Y; Yu AM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):579-82. PubMed ID: 18947473
[TBL] [Abstract][Full Text] [Related]
17. Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children.
Tsai HY; Huang LM; Chiu HH; Hsueh PR; Lee PI; Lu CY; Chiu TF; Lin HC; Lee CY
J Microbiol Immunol Infect; 1998 Sep; 31(3):165-70. PubMed ID: 10496153
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of a new oral cephalosporin, cefprozil, in pediatrics].
Woo M; Higashino H; Kohdera U; Nakamura M; Kawasaki H; Kino M; Kobayashi Y
Jpn J Antibiot; 1992 Dec; 45(12):1635-41. PubMed ID: 1289581
[TBL] [Abstract][Full Text] [Related]
19. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
Hayashi I; Ohnuma K
Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
[TBL] [Abstract][Full Text] [Related]
20. Cefaclor--summary of clinical experience.
Kammer RB; Short LJ
Postgrad Med J; 1979; 55 Suppl 4():93-9. PubMed ID: 548945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
